The DOI matches its Crossref record; 259 of the 259 references it cites were found in a registry or an index.
Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes
Open accessAbstract
Type 2 diabetes mellitus (T2DM) is associated with increased total plasma free fatty acid (FFA) concentrations and an elevated risk of cardiovascular disease. The exact mechanisms by which the plasma FFA profile of subjects with T2DM changes is unclear, but it is thought that dietary fats and changes to lipid metabolism are likely to contribute. Therefore, establishing the changes in concentrations of specific FFAs in an individual’s plasma is important. Each type of FFA has different effects on physiological processes, including the regulation of lipolysis and lipogenesis in adipose tissue, inflammation, endocrine signalling and the composition and properties of cellular membranes. Alterations in such processes due to altered plasma FFA concentrations/profiles can potentially result in the development of insulin resistance and coagulatory defects. Finally, fibrates and statins, lipid-regulating drugs prescribed to subjects with T2DM, are also thought to exert part of their beneficial effects by impacting on plasma FFA concentrations. Thus, it is also interesting to consider their effects on the concentration of FFAs in plasma. Collectively, we review how FFAs are altered in T2DM and explore the likely downstream physiological and pathological implications of such changes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–259 of 259
Pentikäinen, P. J., Voutilainen, E., Aro, A., et al. (1990) · Annals of Medicine · doi:10.3109/07853899009147912 · Cited by 55
Metabolic effects of darglitazone, an insulin sensitizer, in NIDDM subjects
Chaiken, R. L., Eckert‐Norton, M., Pasmantier, R., Boden, G., Ryan, I., Gelfand, R. A., & Lebovitz, H. E. (1995) · Diabetologia · doi:10.1007/bf00401763 · Cited by 54
Chen, X., Stein, T. P., Steer, R. A., & Scholl, T. O. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000632 · Cited by 54
Dietary stimulators of GLUT4 expression and translocation in skeletal muscle: A mini‐review
Gannon, N. P., Conn, C. A., & Vaughan, R. A. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400414 · Cited by 53
Sahebkar, A., Simental‐Mendía, L. E., Pedone, C., Ferretti, G., Nachtigal, P., Bo, S., Derosa, G., Maffioli, P., & Watts, G. F. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12854 · Cited by 53
Kerényi, Z., Samer, H., James, R., Yan, Y., & Stewart, M. W. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.09.009 · Cited by 52
Dietary Fats and the Diabetic Patient
Kinsell, L. W., Walker, G., Michaels, G. D., Olson, F., COELHO, M., McBride, Y., Fukayama, G., & Conklin, J. (1959) · New England Journal of Medicine · doi:10.1056/nejm195908272610904 · Cited by 52
Kassaar, O., Schwarz‐Linek, U., Blindauer, C. A., & Stewart, A. J. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12771 · Cited by 51
Fatty acid sensing in the gut and the hypothalamus: In vivo and in vitro perspectives
Duca, F. A., & Yue, J. T. Y. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.022 · Cited by 51
Mussoni, L., Mannucci, L., Sirtori, C. R., Pazzucconi, F., Bonfardeci, G., Cimminiello, C., Notarbartolo, A., Scafidi, V., Bon, G. B., Alessandrini, P., et al. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00283-x · Cited by 50
Ratnayake, W. N. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.105379 · Cited by 49
Matsuba, I., Matsuba, R., Ishibashi, S., Yamashita, S., Arai, H., Yokote, K., Suganami, H., & Araki, E. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12845 · Cited by 49
Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review
Balk, E. M., Adam, G. P., Langberg, V., Halladay, C., Chung, M., Lin, L., Robertson, S., Yip, A., Steele, D., Smith, B. T., et al. (2016) · doi:10.23970/ahrqepcerta223 · Cited by 47
Zinc Status Affects Glucose Homeostasis and Insulin Secretion in Patients with Thalassemia
Fung, E. B., Gildengorin, G. L., Talwar, S., Hagar, L., & Lal, A. (2015) · Nutrients · doi:10.3390/nu7064296 · Cited by 47
Omega-3 and Omega-6 Fatty Acids and Type 2 Diabetes
Jeppesen, C., Schiller, K., & Schulze, M. B. (2013) · Current Diabetes Reports · doi:10.1007/s11892-012-0362-8 · Cited by 45
Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia
Jonkers, I. J. A. M., de Man, F. H. A. F., van der Laarse, A., Frölich, M., Leuven, J. A. G., Kamper, A. M., Blauw, G. J., & Smelt, A. H. M. (2001) · Journal of Hypertension · doi:10.1097/00004872-200104000-00012 · Cited by 43
Krysiak, R. G., Żmuda, W., & Okopień, B. (2013) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12057 · Cited by 42
Drew, B. G., Carey, A. L., Natoli, A. K., Formosa, M. F., Vizi, D., Reddy-Luthmoodoo, M., Weir, J. M., Barlow, C. K., van Hall, G., Meikle, P. J., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.p012518 · Cited by 42
Combined Use of Rosiglitazone and Fenofibrate in Patients With Type 2 Diabetes
Boden, G. H., Homko, C. J., Mozzoli, M. A., Zhang, M., Kresge, K. M., & Cheung, P. (2006) · Diabetes · doi:10.2337/db06-0481 · Cited by 42
Poudyal, H., & Brown, L. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.07.002 · Cited by 41
Farsi, P. F., Djazayery, A., Eshraghian, M. R., Koohdani, F., Saboor-Yaraghi, A. A., Derakhshanian, H., Zarei, M., Javanbakht, M. H., & Djalali, M. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000002861 · Cited by 40
James, A. P., Watts, G. F., & Mamo, J. C. L. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00407.x · Cited by 40
Abbasi, F., Chen, Y.-D. I., Farin, H. M. F., Lamendola, C. A., & Reaven, G. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.097 · Cited by 40
Punthakee, Z., Alméras, N., Després, J., Dagenais, G. R., Anand, S. S., Hunt, D. L., Sharma, A. M., Jung, H. S., Yusuf, S., & Gerstein, H. C. (2014) · Diabetic Medicine · doi:10.1111/dme.12512 · Cited by 39
Sane, T., Knudsen, P., Vuorinen-Markkola, H., Yki‐Järvinen, H., & Taskinen, M. (1995) · Metabolism · doi:10.1016/0026-0495(95)90115-9 · Cited by 39
Rosiglitazone Prevents Free Fatty Acid-Induced Vascular Endothelial Dysfunction
Mittermayer, F., Schaller, G., Pleiner, J., Krzyżanowska, K., Kapiotis, S., Roden, M., & Wolzt, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2130 · Cited by 38
Anti-Inflammatory and Insulin-Sensitizing Effects of Free Fatty Acid Receptors
Miyamoto, J., Kasubuchi, M., Nakajima, A., & Kimura, I. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_47 · Cited by 38
Regulation of Fasting Fuel Metabolism by Toll-Like Receptor 4
Pang, S., Tang, H., Zhuo, S., Zang, Y. Q., & Le, Y. (2010) · Diabetes · doi:10.2337/db10-0418 · Cited by 37
Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome
Vega, G. L., Cater, N. B., Hadizadeh, D. R., Meguro, S., & Grundy, S. M. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00170-x · Cited by 36
Dranse, H. J., Kelly, M. E. M., & Hudson, B. D. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12327 · Cited by 35
Fat Modification in the Diabetes Diet
Julius, U. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-39230 · Cited by 35
Avogaro, A. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05437-n · Cited by 34
Kanda, S., Nakashima, R., Takahashi, K., Tanaka, J., Ogawa, J., Ogata, T., Yachi, M., Araki, K., & Ohsumi, J. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09084fp · Cited by 33
Carbohydrate dependence during prolonged simulated cycling time trials
Torrens, S., Areta, J. L., Parr, E. B., & Hawley, J. A. (2016) · European Journal of Applied Physiology · doi:10.1007/s00421-016-3333-y · Cited by 33
Buysschaert, M., Bobbioni, E., Starkie, M., Frith, L., & For The Troglitazone Study Group (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00029.x · Cited by 32
Krysiak, R. G., & Okopień, B. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.09.034 · Cited by 31
Metformin and metoprolol CR treatment in non‐obese men
Landin‐Wilhelmsen, K., Tengborn, L., & Smith, U. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01083.x · Cited by 31
Wagner, J. A., Larson, P., Weiss, S., Miller, J., Doebber, T. W., Wu, M., Moller, D. E., & Gottesdiener, K. M. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004273136 · Cited by 30
de Ubago, M. M., Garcia‐Oya, I., Pérez‐Pérez, A., Canfrán‐Duque, A., Quintana‐Portillo, R., de Fonseca, F. R., González-Yanes, C., & Sánchez‐Margalet, V. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.03.014 · Cited by 27
Jeng, C. Y., Sheu, W. H., Fuh, M. M.-T., Shieh, S.-M., Chen, Y. I., & Reaven, G. M. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.7.8675576 · Cited by 26
Therapeutic Role and Ligands of Medium- to Long-Chain Fatty Acid Receptors
Hara, T., Ichimura, A., & Hirasawa, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00083 · Cited by 26
Gormsen, L. C., Søndergaard, E., Christensen, N. L., Jakobsen, S., Nielsen, E. N., Munk, O. L., Tolbod, L. P., Jessen, N., & Nielsen, S. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13244 · Cited by 26
Extended-Release Niacin Acutely Suppresses Postprandial Triglyceridemia
Usman, M., Qamar, A., Gadi, R., Lilly, S., Goel, H., Hampson, J., Mucksavage, M. L., Nathanson, G. A., Rader, D. J., & Dunbar, R. L. (2012) · American Journal of Medicine · doi:10.1016/j.amjmed.2012.03.017 · Cited by 25
Circulating linoleic acid and alpha-linolenic acid and glucose metabolism: the Hoorn Study
Cabout, M., Alssema, M., Nijpels, G., Stehouwer, C. D. A., Zock, P. L., Brouwer, I. A., Elshorbagy, A. K., Refsum, H., & Dekker, J. M. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1261-6 · Cited by 25
Andersson-Hall, U. K., Carlsson, N., Sandberg, A., & Holmäng, A. B. (2018) · Nutrients · doi:10.3390/nu10111629 · Cited by 25
Hwang, Y., Jun, J. E., Jeong, I., Ahn, K. J., & Chung, H. Y. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0124 · Cited by 25
Vega, G. L., Dunn, F. L., & Grundy, S. M. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.011 · Cited by 22
Dobbins, R. L., Byerly, R., Gaddy, R., Gao, F., Mahar, K. M., Napolitano, A., Ambery, P., & de Gouville, A. L. M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.005 · Cited by 21
Free Fatty Acids Modulate Thrombin Mediated Fibrin Generation Resulting in Less Stable Clots
Tanka‐Salamon, A., Komorowicz, E., Szabó, L. F., Tenekedjiev, K. I., & Kolev, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167806 · Cited by 21
Barre, D. E., Mizier-Barre, K. A., Griscti, O., & Hafez, K. (2016) · Endocrine Regulations · doi:10.1515/enr-2016-0020 · Cited by 21
Combination Therapy with Metformin and Fenofibrate for Insulin Resistance in Obesity
Xm, L., Li, Y., Zhang, N.-N., Xie, Y.-H., & Shi, Y. Q. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900531 · Cited by 19
Ma, X., Meng, L., Li, L., Ma, L., & Mao, X. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-121263 · Cited by 19
Vuorinen-Markkola, H., Yki-Järvinen, H., & Taskinen, M. (1993) · Diabetologia · doi:10.1007/bf00400699 · Cited by 18
Intravenous Niacin Acutely Improves the Efficiency of Dietary Fat Storage in Lean and Obese Humans
Nelson, R. H., Vlazny, D. T., Smailovic, A., & Miles, J. M. (2012) · Diabetes · doi:10.2337/db12-0236 · Cited by 17
Effect of Bezafibrate on Metabolic Profiles in Non‐Insulin‐Dependent Diabetes Mellitus
Alberti, K., Jones, R., Laker, M., Swai, A., & Taylor, R. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199000169-00005 · Cited by 17
Avogaro, A., Piliego, T., Catapano, A. L., et al. (1999) · Acta Diabetologica · doi:10.1007/s005920050141 · Cited by 13
Sugiyama, S., Jinnouchi, H., Hieshima, K., Kurinami, N., Suzuki, T., MIYAMOTO, F., Kajiwara, K., Matsui, K., & Jinnouchi, T. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0028-z · Cited by 12
Calvert, G. D., Blight, L. F., Franklin, J., Oliver, J. R., Wise, P., & Gallus, A. S. (1980) · European Journal of Clinical Pharmacology · doi:10.1007/bf00558448 · Cited by 12
The effect of ezetimibe on adipose tissue hormones in patients with isolated hypercholesterolemia
Krysiak, R. G., Żmuda, W., & Okopień, B. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.03.006 · Cited by 10
Cited by
Adipose tissue and insulin resistance in obese
Ahmed, B., Sultana, R., & Greene, M. W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111315 · Cited by 1,047
Ma, X., Xiao, L., Liu, L., Ye, L., Su, P., Bi, E., Wang, Q., Yang, M., Qian, J., & Yi, Q. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.02.015 · Cited by 1,005
Krämer, J., Kang, R., Grimm, L. M., De Cola, L., Picchetti, P., & Biedermann, F. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00746 · Cited by 449
Distinct longevity mechanisms across and within species and their association with aging
Tyshkovskiy, A., Ma, S., Shindyapina, A. V., Tikhonov, S., Lee, S.-G., Bozaykut, P., Castro, J. P., Seluanov, A., Schork, N. J., Gorbunova, V., et al. (2023) · Cell · doi:10.1016/j.cell.2023.05.002 · Cited by 162
Early pregnancy plasma fatty acid profiles of women later diagnosed with gestational diabetes
Tryggvadottir, E. A., Gunnarsdottir, I., Birgisdottir, B. E., Hrolfsdottir, L., Landberg, R., Hreidarsdottir, I. T., Hardardottir, H., & Halldorsson, T. I. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002326 · Cited by 16
Metadata
- Authors
- I. S. Sobczak, A., A. Blindauer, C., & J. Stewart, A.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-08-28
- Volume
- 11
- Issue
- 9
- Pages
- 2022
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2971291901
- Cited by
- 304
- References
- 259
- FWCI
- 22.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.